454 related articles for article (PubMed ID: 8706727)
1. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
[TBL] [Abstract][Full Text] [Related]
2. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
[TBL] [Abstract][Full Text] [Related]
4. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
[TBL] [Abstract][Full Text] [Related]
5. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5).
de Meester I; Vanhoof G; Lambeir AM; Scharpé S
J Immunol Methods; 1996 Jan; 189(1):99-105. PubMed ID: 8576585
[TBL] [Abstract][Full Text] [Related]
6. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
7. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
[TBL] [Abstract][Full Text] [Related]
8. The structure and function of CD26 in the T-cell immune response.
Morimoto C; Schlossman SF
Immunol Rev; 1998 Feb; 161():55-70. PubMed ID: 9553764
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
10. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding.
Yu DM; Slaitini L; Gysbers V; Riekhoff AG; Kähne T; Knott HM; De Meester I; Abbott CA; McCaughan GW; Gorrell MD
Scand J Immunol; 2011 Feb; 73(2):102-11. PubMed ID: 21198750
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.
Blanco J; Marié I; Callebaut C; Jacotot E; Krust B; Hovanessian AG
Exp Cell Res; 1996 May; 225(1):102-11. PubMed ID: 8635502
[TBL] [Abstract][Full Text] [Related]
14. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).
Kahne T; Lendeckel U; Wrenger S; Neubert K; Ansorge S; Reinhold D
Int J Mol Med; 1999 Jul; 4(1):3-15. PubMed ID: 10373631
[TBL] [Abstract][Full Text] [Related]
16. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
[TBL] [Abstract][Full Text] [Related]
17. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
Hühn J; Olek S; Fleischer B; von Bonin A
Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
[TBL] [Abstract][Full Text] [Related]
18. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
Smith RE; Talhouk JW; Brown EE; Edgar SE
AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
[TBL] [Abstract][Full Text] [Related]
19. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
20. A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26).
Duke-Cohan JS; Morimoto C; Rocker JA; Schlossman SF
J Biol Chem; 1995 Jun; 270(23):14107-14. PubMed ID: 7539799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]